“The prospective multi-center trial of at least 65 patients will compare the clinical performance of conventional skin grafting to the use of the RECELL System in combination with more widely meshed autografts on acute full-thickness non-burn skin defects. The study’s two primary effectiveness endpoints are:Superior donor skin sparing, evaluated by comparing the actual expansion ratios of donor skin used to treat the wounds Non-inferior incidence of healing by eight weeks post treatment Healing will be evaluated by a qualified clinician blinded to the treatment allocation. Additional long-term safety and effectiveness data collected over the course of the 52-week study will include blinded evaluation of scar outcomes and patient treatment preference.”
Looks to me that this company has done a lot more than just surveys... Bit more research needed for you I think mate.
“The prospective multi-center trial of at least 65 patients will...
Add AVH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.67 |
Change
-0.060(2.20%) |
Mkt cap ! $160.7M | |||
| Open | High | Low | Value | Volume |
| $2.72 | $2.73 | $2.65 | $791.0K | 293.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 4333 | $2.67 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.68 | 9529 | 1 |
View Market Depth
| Last trade - 16.10pm 03/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$2.66 |
Change
-0.060 ( 3.24 %) |
||||
| Open | High | Low | Volume | ||
| $2.71 | $2.73 | $2.65 | 25459 | ||
| Last updated 15.53pm 03/05/2024 ? | |||||
| AVH (ASX) Chart |